The MaxWell Collective
A science-driven, innovative medical technology company in development powered by a team of exceptional individuals. We are dedicated to advancing long-term, non-destructive solutions for patients with atrial fibrillation and HFpEF. Through cutting-edge research and relentless innovation, we’re pushing the boundaries of cardiac care to transform patient outcomes.
One team. One rhythm. One Mission.
Randy Werneth
Randy leads the Collective's mission with a founder's instinct sharpened across multiple MedTech Ventures, but he will tell you this one stands out as his most exciting and challenging yet. This is why he loves start-ups. Ownership is taken here, starting with him.
Timothy Corvi
Our collective master maestro of product development. Tim brings 20+ years engineering breakthrough devices across cardiology and electrophysiology, along with the ability to build boldly without compromising integrity.
Derrick Chou, PhD
Our collective spark and brainiac. Formerly CTO at Acutus Medical, Derrick finds what the rest of us miss. A mind for creative problem-solving, wired for the Collective's shared prusuit of healing over harm.
Ben Coppola, PhD
Ben charts the course to treat AF at its source, restoring rhythm without destroying tissue. The first to notice is the first to act, and Ben does this well.
Walter Bomela, PhD
Walter keeps every heartbeat in sync, blending technical expertise with creative flair. He is proof that the imagination and integrity are not opposites.
J. Chris Flaherty
Chris turns complex ideas into actionable patent strategies, and fuels the Collective's work to protect the revolution happening in cardiac care. What we build together deserves to be defended together.